News

Harold Litt named new editor of RSNA's cardiothoracic imaging journal

Litt, a leading name in the fields of radiology and cardiology, has been with the journal since it was first launched in 2019.

Hospital for Special Surgery pediatric MRI

Vigilance needed to ensure safety in pediatric MR imaging, experts warn

The conclusions are based on an analysis of safety data from five leading pediatric hospitals, spanning 2017 to 2022, published in JACR.

President Trump's presidential proclamation Sept. 19 to implement a $100,000 fee for H-1B visa applications had immediate backlash from dozens of medical societies. Groups like the American Medical Association (AMA) and the American College of Cardiology (ACC) said this will cut off the flow of foreign physicians into the U.S. at a time when we cannot graduate enough American physicians to fill positions in a healthcare system that is facing a rapidly growing physician shortage.

Administration quietly lifts hold on immigration applications for radiologists and other docs

This comes after medical societies and immigration attorneys have for months sought exemptions for physicians, given widespread staffing shortages.

RadNet revises financial projections upward after ‘record’ quarter, with revenue up 22%

This comes after RadNet executed several acquisitions so far this year, including buying French AI firm Gleamer for approximately $270 million.

‘Population autopsy’ finds the US with more avoidable deaths than other wealthy countries

The United States appears to be leading all high-income countries in an unfortunate, distinctly undesirable statistical category.

New ultrasound needle yielded more substantial tissue samples

New ultrasound needle could significantly improve tissue yield during biopsies

Vibrating at up to 30,000 times per second, the sonographic device helps tissue to detach more easily without inflicting a large puncture wound to collect an adequate amount of tissue.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Bayer's new imaging agent for cardiac amyloidosis impresses in clinical trial

The REVEAL study has been assessing the sensitivity and specificity of iodine 124 evuzamitide (I 124 evuzamitide), a PET agent capable of visualizing signs of cardiac amyloidosis on imaging.

Florida doctor charged with manslaughter in patient death describes chaotic scene in deposition

NBC News obtained a copy of the November deposition, linked to a civil lawsuit against Thomas Shaknovsky, MD, accused of removing a patient’s liver instead of spleen, killing him. The surgeon, who has lost his license to practice medicine in Florida, has also been criminally charged with second degree manslaughter. He denies any intentional wrongdoing.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

New gene therapy for rare heart condition gains FDA’s fast track designation

Catecholaminergic polymorphic ventricular tachycardia is a rare, potentially fatal heart rhythm disorder. A new gene therapy candidate from Solid Biosciences is now one step closer to FDA approval.

Philips UroNav system gains FDA clearance

FDA clears fusion image navigation system for prostate cancer therapy planning

The fusion technology integrates pre-procedural MR images of the prostate with intraprocedural ultrasound images in real-time.

Joshua Joseph, MD, MPH, FAHA an expert in Cardiovascular-Kidney-Metabolic (CKM) syndrome, associate professor of internal medicine, and the Endowed Professor for Research in Internal Medicine in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University Wexner Medical Center, explains the CKM advisory from the American Heart Association designed to help define and stage the disease. CKM has seen a large amount of growing interest from cardiologists in recent years.

Interest rising in CKM syndrome as connections become clearer

Cardiovascular-kidney-metabolic (CKM) syndrome is a popular research topic among cardiologists, highlighting just how closely obesity, type 2 diabetes, chronic kidney disease and cardiovascular disease are related to one another. Joshua Joseph, MD, spoke to Cardiovascular Business about this ongoing trend.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Complications after intravascular lithotripsy are rare, real-world data confirm

Shockwave Medical, now a part of Johnson & Johnson MedTech, has consistently been found safe for patients. However, many previous clinical trials excluded high-risk patients, making it important to track real-world outcomes as time goes on.

Around the web

Cardiovascular Business